PPAR Research

PPAR Research / 2018 / Article

Erratum | Open Access

Volume 2018 |Article ID 5480829 | https://doi.org/10.1155/2018/5480829

Kay-Dietrich Wagner, Ana Vukolic, Delphine Baudouy, Jean-François Michiels, Nicole Wagner, "Erratum to “Inducible Conditional Vascular-Specific Overexpression of Peroxisome Proliferator-Activated Receptor Beta/Delta Leads to Rapid Cardiac Hypertrophy”", PPAR Research, vol. 2018, Article ID 5480829, 4 pages, 2018. https://doi.org/10.1155/2018/5480829

Erratum to “Inducible Conditional Vascular-Specific Overexpression of Peroxisome Proliferator-Activated Receptor Beta/Delta Leads to Rapid Cardiac Hypertrophy”

Received18 Sep 2018
Accepted20 Sep 2018
Published29 Oct 2018

In the article titled “Inducible Conditional Vascular-Specific Overexpression of Peroxisome Proliferator-Activated Receptor Beta/Delta Leads to Rapid Cardiac Hypertrophy” [1], there are errors in Figures 1, 2, and 5. In Figure 1, some of the images were not representative. A higher resolution figure is provided from the authors. In Figures 2 and 5, the images of hearts are supposed to be of different sizes. Due to production errors, the images were all the same size. The corrected figures are shown below.

References

  1. K.-D. Wagner, A. Vukolic, D. Baudouy, J.-F. Michiels, and N. Wagner, “Inducible conditional vascular-specific overexpression of peroxisome proliferator-activated receptor beta/delta leads to rapid cardiac hypertrophy,” PPAR Research, vol. 2016, Article ID 7631085, 12 pages, 2016. View at: Publisher Site | Google Scholar

Copyright © 2018 Kay-Dietrich Wagner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views734
Downloads337
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.